• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

社会经济地位对头颈部癌症患者生存的影响。

Effect of socioeconomic status on survival in patients with head and neck cancer.

机构信息

Azrieli Faculty of Medicine, Bar-Ilan University Safed, Safed, Israel.

Department of Otolaryngology Head and Neck Surgery, Galilee Medical Center, Nahariya, Israel.

出版信息

Head Neck. 2021 Oct;43(10):3001-3009. doi: 10.1002/hed.26788. Epub 2021 Jun 16.

DOI:10.1002/hed.26788
PMID:34137115
Abstract

BACKGROUND

The aim of this study was to assess the survival outcomes of head and neck cancer (HNC) by socioeconomic status.

METHODS

A national retrospective population-based cohort of HNC patients diagnosed in Israel between 2000 and 2017 was conducted. Site of residence and socioeconomic status were correlated with overall survival (OS), controlling for prognostic factors that included tumor site, stage, age, sex, and ethnic group.

RESULTS

Overall, 11 826 patients were identified. Patients from high socioeconomic areas had better overall 5-year survival than patients from low socioeconomic areas (p < 0.005). Patients in stage 3 from a high socioeconomic status had a longer median survival rate of 1.5 years than patients in the low-status group. In a cox proportional hazards analysis, we found age >65 (HR 2.91, 95% confidence interval [CI]: 2.75-3.09, p < 0.001) and low socioeconomic group (HR 1.25, 95% CI: 1.18-1.33, p < 0.001) to be correlated with inferior OS.

CONCLUSION

Our findings show that patients with HNC living in low socioeconomic areas had worse OS.

摘要

背景

本研究旨在评估头颈部癌症(HNC)的生存结局与社会经济地位之间的关系。

方法

本研究对 2000 年至 2017 年间在以色列被诊断为 HNC 的患者进行了全国性回顾性基于人群的队列研究。居住地和社会经济地位与总体生存率(OS)相关,同时控制了肿瘤部位、分期、年龄、性别和种族等预后因素。

结果

共纳入 11826 例患者。来自高社会经济地区的患者的总体 5 年生存率优于来自低社会经济地区的患者(p<0.005)。处于 3 期且社会经济地位较高的患者的中位生存时间比社会经济地位较低的患者长 1.5 年。在 Cox 比例风险分析中,我们发现年龄>65 岁(HR 2.91,95%置信区间 [CI]:2.75-3.09,p<0.001)和低社会经济群体(HR 1.25,95% CI:1.18-1.33,p<0.001)与较差的 OS 相关。

结论

我们的研究结果表明,居住在低社会经济地区的 HNC 患者的 OS 较差。

相似文献

1
Effect of socioeconomic status on survival in patients with head and neck cancer.社会经济地位对头颈部癌症患者生存的影响。
Head Neck. 2021 Oct;43(10):3001-3009. doi: 10.1002/hed.26788. Epub 2021 Jun 16.
2
Urban and rural differences in outcomes of head and neck cancer.头颈癌治疗结果的城乡差异。
Laryngoscope. 2018 Apr;128(4):852-858. doi: 10.1002/lary.26836. Epub 2017 Sep 20.
3
Treatment delays, race, and outcomes in head and neck cancer.头颈部癌症的治疗延误、种族与结局。
Cancer Epidemiol. 2016 Dec;45:18-25. doi: 10.1016/j.canep.2016.09.005. Epub 2016 Sep 22.
4
Head and neck cancer-specific survival based on socioeconomic status in Asians and Pacific Islanders.亚洲人和太平洋岛民基于社会经济地位的头颈部癌症特异性生存。
Cancer. 2011 May 1;117(9):1935-45. doi: 10.1002/cncr.25723. Epub 2010 Nov 10.
5
Socioeconomic disparities in head and neck cancer survival in Germany: a causal mediation analysis using population-based cancer registry data.德国头颈部癌症生存的社会经济差异:基于人群癌症登记数据的因果中介分析。
J Cancer Res Clin Oncol. 2021 May;147(5):1325-1334. doi: 10.1007/s00432-021-03537-2. Epub 2021 Feb 11.
6
Association of Type of Treatment Facility With Overall Survival After a Diagnosis of Head and Neck Cancer.治疗机构类型与头颈部癌症诊断后总生存的关联。
JAMA Netw Open. 2020 Jan 3;3(1):e1919697. doi: 10.1001/jamanetworkopen.2019.19697.
7
Effectiveness Outcomes in Patients With Recurrent or Refractory Head and Neck Cancers: Retrospective Analysis of Data From a Community Oncology Database.复发性或难治性头颈部癌症患者的疗效结果:来自社区肿瘤学数据库的回顾性数据分析。
Clin Ther. 2018 Sep;40(9):1522-1537. doi: 10.1016/j.clinthera.2018.07.016. Epub 2018 Aug 25.
8
Quality of life scores as prognostic factors of overall survival in advanced head and neck cancer: analysis of a phase III randomized trial of pemetrexed plus cisplatin versus cisplatin monotherapy.生活质量评分作为晚期头颈部癌症总生存的预后因素:培美曲塞联合顺铂与顺铂单药治疗的 III 期随机试验分析。
Oral Oncol. 2012 Aug;48(8):723-9. doi: 10.1016/j.oraloncology.2012.02.016. Epub 2012 Mar 11.
9
Survival benefit of post-operative chemotherapy for intermediate-risk advanced stage head and neck cancer differs with patient age.术后化疗对中危期头颈部癌症的生存获益因患者年龄而异。
Oral Oncol. 2018 Sep;84:71-75. doi: 10.1016/j.oraloncology.2018.07.012. Epub 2018 Jul 21.
10
Head and Neck Cancer Survival Disparities by Race and Rural-Urban Context.头颈部癌症的生存差异与种族和城乡背景有关。
Cancer Epidemiol Biomarkers Prev. 2020 Oct;29(10):1955-1961. doi: 10.1158/1055-9965.EPI-20-0376. Epub 2020 Jul 29.

引用本文的文献

1
Rurality, Health Care Resource Use, and Care Trajectories in Patients With Head and Neck Cancer.头颈癌患者的农村地区情况、医疗保健资源利用及护理轨迹
JAMA Netw Open. 2025 Apr 1;8(4):e254675. doi: 10.1001/jamanetworkopen.2025.4675.
2
Tumor Cell Stemness and Stromal Cell Features Contribute to Oral Cancer Outcome Disparity in Black Americans.肿瘤细胞干性和基质细胞特征导致美国黑人口腔癌预后差异
Cancers (Basel). 2024 Jul 31;16(15):2730. doi: 10.3390/cancers16152730.
3
Psychological Factors Related to Treatment Outcomes in Head and Neck Cancer.
心理因素与头颈部癌症治疗结果的关系。
Adv Ther. 2024 Sep;41(9):3489-3519. doi: 10.1007/s12325-024-02945-3. Epub 2024 Aug 7.
4
Psychosocial factors and patient and healthcare delays in large (class T3-T4) oral, oropharyngeal, and laryngeal carcinomas.大型(T3-T4 期)口腔、口咽和喉癌患者的社会心理因素及医疗延误。
BMC Cancer. 2024 Jun 25;24(1):760. doi: 10.1186/s12885-024-12517-x.
5
Pharmacological impact of microRNAs in head and neck squamous cell carcinoma: Prevailing insights on molecular pathways, diagnosis, and nanomedicine treatment.微小RNA在头颈部鳞状细胞癌中的药理作用:关于分子途径、诊断及纳米医学治疗的当前见解
Front Pharmacol. 2023 May 3;14:1174330. doi: 10.3389/fphar.2023.1174330. eCollection 2023.
6
The Intersectionality between Race, Ethnicity, and Residential-Level Socioeconomic Status in Disparities of Head and Neck Cancer Outcomes: A SEER Study.种族、民族与居住地区社会经济地位在头颈部癌症结局差异中的交叉性:一项 SEER 研究。
Cancer Epidemiol Biomarkers Prev. 2023 Apr 3;32(4):516-523. doi: 10.1158/1055-9965.EPI-22-1167.
7
Insights into Nanomedicine for Head and Neck Cancer Diagnosis and Treatment.头颈部癌症诊断与治疗的纳米医学见解
Materials (Basel). 2022 Mar 11;15(6):2086. doi: 10.3390/ma15062086.